Quoin Pharmaceuticals Ltd - ADR

NASDAQ:QNRX   3:58:59 PM EDT
0.39
+0.04 (+10.11%)
Products

Quoin Pharmaceuticals Enters Exclusive Research Agreement For Scleroderma Treatment With Australian University

Published: 05/23/2022 13:02 GMT
Quoin Pharmaceuticals Ltd - ADR (QNRX) - Quoin Pharmaceuticals Enters Exclusive Research Agreement for Scleroderma Treatment With Australian University.
Quoin Pharmaceuticals Ltd - Quoin Will Fund Pre-clinical Program and Will Have an Option to Exclusive Global Rights to Product.
Quoin Pharmaceuticals Ltd - Terms of Deal Do Not Require Quoin to Pay Any Upfront Or Milestone Fees.
Quoin Pharmaceuticals Ltd - Upon Commercialization, Company Would Pay a Mid-single Digit Royalty on Sales.